STAQ Pharma is an FDA-registered 503B outsourcing facility that provides compounded medications to healthcare providers, ensuring consistent availability during drug shortages. By implementing rigorous quality control and transparent practices, STAQ Pharma delivers safe and reliable medications to support patient care across various medical specialties.
Funding
$30M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.


Founders
Product
Problem
Hospitals and healthcare providers frequently face drug shortages, which can disrupt patient care and compromise treatment outcomes. These shortages necessitate finding alternative medications or treatment plans, potentially leading to increased costs and risks. Maintaining a consistent supply of essential medications is critical for ensuring patient safety and effective healthcare delivery.
Solution
STAQ Pharma is an FDA-registered 503B outsourcing facility that partners with hospitals and healthcare systems to combat drug shortages and ensure a reliable supply of essential medications. By adhering to cGMP standards in its state-of-the-art facilities, STAQ Pharma delivers high-quality compounded preparations across various medical specialties, including oncology, anesthesia, and emergency care. The company focuses on safety, transparency, availability, and quality, working closely with healthcare providers to address their specific needs and provide vital medications during times of crisis. STAQ Pharma's portfolio includes syringes, IV bags, vials, and ON-Q pumps, with a growing emphasis on oncology medications to support pediatric and adult cancer patients.
Target Audience
STAQ Pharma primarily serves hospitals, healthcare systems, ambulatory surgery centers, and healthcare facilities that require a reliable supply of compounded medications to address drug shortages and support patient care.
Features
- FDA-registered 503B outsourcing facility
- cGMP-compliant manufacturing processes
- Specialization in sterile injectable medications
- Focus on addressing drug shortages in critical areas like oncology and emergency care
- Hospital-owned model for precise alignment with healthcare provider needs
- Extensive product portfolio including syringes, IV bags, and vials
- Capability to produce hazardous drugs, such as oncology medications
- Batch testing and quality control processes